Jennison Associates LLC Has $122.17 Million Position in UnitedHealth Group Incorporated $UNH

Jennison Associates LLC reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 22.0% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 391,594 shares of the healthcare conglomerate’s stock after selling 110,482 shares during the quarter. Jennison Associates LLC’s holdings in UnitedHealth Group were worth $122,166,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in the stock. Atlantic Edge Private Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 8.9% in the first quarter. Atlantic Edge Private Wealth Management LLC now owns 305 shares of the healthcare conglomerate’s stock valued at $160,000 after buying an additional 25 shares during the period. HHM Wealth Advisors LLC lifted its stake in shares of UnitedHealth Group by 0.9% in the first quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock valued at $1,544,000 after buying an additional 26 shares during the period. Brogan Financial Inc. lifted its stake in shares of UnitedHealth Group by 3.4% in the first quarter. Brogan Financial Inc. now owns 819 shares of the healthcare conglomerate’s stock valued at $429,000 after buying an additional 27 shares during the period. West Wealth Group LLC lifted its stake in shares of UnitedHealth Group by 3.2% in the first quarter. West Wealth Group LLC now owns 882 shares of the healthcare conglomerate’s stock valued at $462,000 after buying an additional 27 shares during the period. Finally, Hemington Wealth Management lifted its stake in UnitedHealth Group by 2.5% during the first quarter. Hemington Wealth Management now owns 1,154 shares of the healthcare conglomerate’s stock worth $604,000 after purchasing an additional 28 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $368.74 on Wednesday. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The firm has a 50 day moving average of $340.88 and a 200-day moving average of $332.70. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The stock has a market capitalization of $333.95 billion, a P/E ratio of 15.98, a price-to-earnings-growth ratio of 2.37 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. During the same quarter in the previous year, the company posted $7.15 EPS. UnitedHealth Group’s revenue was up 12.2% on a year-over-year basis. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s payout ratio is 38.30%.

Wall Street Analyst Weigh In

A number of research analysts have commented on UNH shares. JPMorgan Chase & Co. raised their price target on shares of UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a research note on Thursday, October 9th. Weiss Ratings upgraded shares of UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, October 24th. Mizuho raised their price target on shares of UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a research note on Thursday, October 9th. Robert W. Baird restated an “underperform” rating and set a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Finally, Wells Fargo & Company lifted their target price on shares of UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research note on Tuesday, October 7th. Eighteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $389.29.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.